Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

By Rosner A.J.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model

By Kreck Simon   Klaus Jochen  

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 311-328

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature

By Fleurence Rachael L.  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 913-933

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

By Willis M.  

Clinical Drug Investigation, Vol. 21, Iss. 2, 2001-02 ,pp. : 115-127

Adis International

Access to resources Recommend Favorite

Cost–Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence

By Hiligsmann Mickaël   Gathon Henry-Jean   Bruyère Olivier   Ethgen Olivier   Rabenda Véronique   Reginster Jean-Yves  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 394-401

Blackwell Publishing

Access to resources Recommend Favorite